Caas Capital Management LP Argenx Se Transaction History

Caas Capital Management LP

  • $836 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$272.01 - $353.03 $15.7 Million - $20.4 Million
-57,886 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$295.0 - $350.58 $17.1 Million - $20.3 Million
57,886 New
57,886 $17.5 Million
Q3 2020

Nov 09, 2020
SELL
$215.51 - $272.51 $8.81 Million - $11.1 Million
-40,899 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$127.44 - $232.72 $5.21 Million - $9.52 Million
40,899 New
40,899 $9.21 Million

Others Institutions Holding ARGX

# of Institutions
400
Shares Held
30.9M
Call Options Held
376K
Put Options Held
489K
View Full List

About ARGENX SE

ARGX Quotes by TradingView
  • Ticker ARGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,323,800
  • Market Cap $31.2B
  • Description
  • argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...
More about ARGX
Track This Portfolio

Track Caas Capital Management LP Portfolio

Follow Caas Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caas Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Caas Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email